🇺🇸 VCEL — Vericel Corporation

Salud Compra fuerte
← Volver

Precio actual

45,48 USD

Máx. histórico

1.410,00

10633 días

Split 1:20 del 16/10/2013

Caída desde máximo

-96,77%

Rango 52 semanas

28,95 – 49,32

Variación hoy

+10,68%

Cierre anterior

41,09

Rango de hoy

42,07 – 45,98

Volumen hoy

1.742.273

Peor caída histórica

-99,88%

24/09/1997 → 17/11/2015

Aún sin recuperar

Volatilidad anualizada ⓘ

97,58%

Información
Nombre completo
Vericel Corporation
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
398
PER ⓘ
96,77 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
59,71 USD (puede no estar actualizado)
Primera cotización
04/02/1997
Precio actualizado
hace 8 horas
Sobre la empresa

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
16/10/2013 1:20
18/02/2010 1:8
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/04/2012 45,00 45,80 43,60 44,80 +2,75% 4,89% 18.385
13/04/2012 44,40 44,60 43,00 43,60 -0,46% 3,60% 16.190
12/04/2012 41,20 44,20 41,20 43,80 +5,29% 7,28% 22.075
11/04/2012 41,00 42,00 40,60 41,60 +1,46% 3,41% 7.970
10/04/2012 42,40 42,40 40,00 41,00 -0,97% 5,66% 13.560
09/04/2012 41,80 43,40 40,60 41,40 +1,97% 6,70% 20.495
05/04/2012 40,00 41,40 39,80 40,60 +1,50% 4,00% 13.160
04/04/2012 39,60 40,00 38,20 40,00 -0,50% 4,55% 10.105
03/04/2012 40,40 40,40 39,40 40,20 +0,00% 2,48% 6.660
02/04/2012 40,40 40,40 39,00 40,20 -0,50% 3,47% 10.980
30/03/2012 40,80 41,20 40,00 40,40 +0,00% 2,94% 16.010
29/03/2012 39,20 40,80 38,80 40,40 +2,54% 5,10% 12.875
28/03/2012 39,40 39,80 39,00 39,40 +1,03% 2,03% 7.775
27/03/2012 38,60 39,60 38,60 39,00 +2,09% 2,59% 10.780
26/03/2012 38,20 39,00 37,40 38,20 +0,00% 4,19% 10.735
23/03/2012 38,40 39,00 37,40 38,20 -0,52% 4,17% 15.515
22/03/2012 38,40 38,80 37,00 38,40 +0,52% 4,69% 15.895
21/03/2012 39,20 39,60 37,40 38,20 -1,55% 5,61% 14.275
20/03/2012 39,60 40,20 38,00 38,80 -2,51% 5,56% 22.630
19/03/2012 40,80 41,80 39,80 39,80 -3,40% 4,90% 22.570
16/03/2012 42,00 42,40 40,80 41,20 -1,90% 3,81% 11.615
15/03/2012 40,60 42,20 40,60 42,00 +2,94% 3,94% 9.610
14/03/2012 41,60 42,20 40,00 40,80 -2,39% 5,29% 20.775
13/03/2012 42,40 43,40 41,20 41,80 +2,45% 5,19% 17.840
12/03/2012 44,00 45,80 40,60 40,80 -7,27% 11,82% 43.445
09/03/2012 36,60 54,40 35,80 44,00 +20,88% 50,82% 193.975
08/03/2012 37,00 37,00 36,40 36,40 -1,62% 1,62% 3.545
07/03/2012 36,40 38,20 35,80 37,00 +2,78% 6,59% 6.490
06/03/2012 37,00 37,40 35,80 36,00 -2,17% 4,32% 6.080
05/03/2012 37,20 37,60 36,00 36,80 -0,54% 4,30% 10.370